Literature DB >> 17644317

Complex regulation of S100A8 by IL-17, dexamethasone, IL-4 and IL-13 in HaCat cells (human keratinocyte cell line).

Bingxue Bai, Kazuo Yamamoto, Hiroshi Sato, Hisashi Sugiura, Toshihiro Tanaka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17644317     DOI： 10.1016/j.jdermsci.2007.06.001

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN： 0923-1811            Impact factor:   4.563


× No keyword cloud information.
  6 in total

1.  ANTI-INFECTIVE PROTECTIVE PROPERTIES OF S100 CALGRANULINS.

Authors:  Kenneth Hsu; Chantrakorn Champaiboon; Brian D Guenther; Brent S Sorenson; Ali Khammanivong; Karen F Ross; Carolyn L Geczy; Mark C Herzberg
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2009-12-04

2.  Morphine disrupts interleukin-23 (IL-23)/IL-17-mediated pulmonary mucosal host defense against Streptococcus pneumoniae infection.

Authors:  Jing Ma; Jinghua Wang; Jing Wan; Richard Charboneau; Yaping Chang; Roderick A Barke; Sabita Roy
Journal:  Infect Immun       Date:  2009-12-07       Impact factor: 3.441

3.  Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis.

Authors:  Julia K Gittler; Avner Shemer; Mayte Suárez-Fariñas; Judilyn Fuentes-Duculan; Kara J Gulewicz; Claire Q F Wang; Hiroshi Mitsui; Irma Cardinale; Cristina de Guzman Strong; James G Krueger; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2012-08-27       Impact factor: 10.793

4.  Antagonistic Effects of IL-4 on IL-17A-Mediated Enhancement of Epidermal Tight Junction Function.

Authors:  Matthew G Brewer; Takeshi Yoshida; Fiona I Kuo; Sade Fridy; Lisa A Beck; Anna De Benedetto
Journal:  Int J Mol Sci       Date:  2019-08-21       Impact factor: 5.923

5.  Comparative Efficacy and Safety of Dupilumab and Benralizumab in Patients with Inadequately Controlled Asthma: A Systematic Review.

Authors:  Koichi Ando; Akihiko Tanaka; Hironori Sagara
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

6.  Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers.

Authors:  A R J V Vossen; H H van der Zee; N Davelaar; A M C Mus; M B A van Doorn; E P Prens
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-12-10       Impact factor: 6.166
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.